MedTrace Logo

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection

NCT00700375 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2010-07-20

Study results available
· View outcomes & findings →

Summary

This study is to investigate the effect of Sodium Bicarbonate bolus injection in patients undergoing an emergent coronary procedure for prevention of contrast-induced nephropathy.

Conditions

  • Emergent Coronary Procedure

Interventions

DRUG

Sodium bicarbonate

8.4%sodium bicarbonate 0.5ml/kg bolus injection before procedure and hydration with 154mEq/l sodium bicarbonate 1ml/kg/Hr for 6 hours after the procedure

DRUG

Sodium Chloride

8.4%sodium bicarbonate 0.5ml/kg bolus injection before procedure and hydration with 154mEq/l sodium bicarbonate 1ml/kg/Hr for 6 hours after the procedure

Sponsors & Collaborators

  • Osaka General Medical Center

    lead OTHER

Principal Investigators

  • Takahisa Yamada, directorate · OsakaGeneralMedicalCenter

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700375 on ClinicalTrials.gov